-
Almost Family Reports Q4 EPS of $0.79 vs. $0.78
Monday, February 28, 2011 - 8:39am | 72Almost Family, Inc. (Nasdaq: AFAM) announced today its financial results for the three-months ended December 31, 2010. Net service revenues increased to approximately $85 million Net income and diluted EPS were $7.0 million and $0.75 per share after the costs of complying with governmental...
-
Earnings Scheduled For February 28 (AES, EIX, AWI, EXM, CDE, LYV, IDIX, AFAM, AONE, RRC, BPHX, BID, DTSI, EPR)
Monday, February 28, 2011 - 2:40am | 373AES Corp (NYSE: AES) is expected to report its Q4 earnings at $0.25 per share on revenue of $3.80 billion. Edison International (NYSE: EIX) is projected to report its Q4 EPS at $0.60 on revenue of $4.20 billion. Armstrong World Industries Inc (NYSE: AWI) is estimated to post its Q4 EPS at $0.16...
-
Top 4 Stocks In The Insurance Brokers Industry With The Highest Cash (CISG, CHSI, EHTH, CRVL)
Monday, February 28, 2011 - 2:36am | 129Below are the top insurance broker stocks on the NYSE and the NASDAQ in terms of cash. CNinsure Inc (NASDAQ: CISG) had $302.85 million in total cash and no debt for the latest quarter. Catalyst Health Solutions Inc (NASDAQ: CHSI) had $132.66 million in total cash for the latest quarter. Meanwhile...
-
Stocks To Watch For February 28 (EIX, BID, RRC, AES, LYV)
Monday, February 28, 2011 - 2:33am | 191Some of the stocks that may grab investor focus today are: Wall Street expects Edison International (NYSE: EIX) to report its Q4 EPS at $0.60 on revenue of $4.20 billion. EIX shares gained 0.59% to close at $36.01 on Friday. Analysts are expecting Sotheby's (NYSE: BID) to have earned $1.32 per...
-
Fast Money Pops & Drops, February 24th (OCR, PCLN, MU, SLXP, NEM)
Thursday, February 24, 2011 - 9:05pm | 251On CNBC's Fast Money, Karen Finerman said that Omnicare's (NYSE: OCR) conference call was pretty good, and she also said that she likes the new CEO. Omnicare, Inc. (OCR) gained 6.41% in the regular trading session, but it surrendered its gains in the after hours. Salix Pharmaceuticals, Ltd. (NASDAQ...
-
Omnicare Reports Q4 EPS of $0.51 vs. $0.51; Revenue 1.56B vs. $1.56B
Thursday, February 24, 2011 - 8:59am | 41Omnicare, Inc. (NYSE: OCR) reported today financial results for its fourth quarter and full year ended December 31, 2010. Net sales were $1,558.4 million as compared with $1,539.7 million Adjusted income from continuing operations per share was $0.51
-
Fresenius Medical Reports Q4 EPS of $0.90
Wednesday, February 23, 2011 - 6:53am | 55Fresenius Medical (NYSE: FMS) reports its Q4 EPS at $0.90, versus the consensus of $0.88. FMS reports its Q4 revenue at $3.17 billion, versus the consensus of $3.17 billion. FMS shares gained 2.32% to $66.10 in pre-market trading. Read more from Benzinga's Company news.
-
Jefferies: Expect MHS To Trade Flat Or Down
Tuesday, February 22, 2011 - 10:45am | 64Medco Health Solutions (NYSE: MHS) posted an in-line Q4 and did not raise guidance, Jefferies reports. “Expect stock to trade flat or down on this news,” Jefferies writes. “MHS reported in-line adjusted 4Q10 EPS of $0.94 on revenues of $16.9B, EBITDA of $786.7MM and EBITDA/adjusted claim of $3.22 (...
-
Omnicare Appoints John L. Workman to the Additional Role of President
Tuesday, February 22, 2011 - 9:16am | 86Omnicare, Inc. (NYSE: OCR) announced today that John L. Workman has been appointed to the additional role of President, effective immediately. He will remain Chief Financial Officer of the Company and will continue to report to John Figueroa, Omnicare's Chief Executive Officer. Mr. Workman, age 59...
-
Chemed Corporation Announces $100M Share Buyback
Tuesday, February 22, 2011 - 8:30am | 55Chemed Corporation (NYSE: CHE) today announced that the Board of Directors has formally authorized $100 million available for stock repurchase under Chemed's share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as...
-
Amedisys Reports Upbeat Q4 Earnings
Tuesday, February 22, 2011 - 8:15am | 56Amedisys Inc (NASDAQ: AMED) reports its Q4 adjusted EPS at $0.95, versus the consensus of $0.90. AMED reports its Q4 revenue at $394.3 million, versus the consensus of $399.58 million. AMED shares fell 0.02% to $38.07 in after-hours trading. Read more from Benzinga's Company news.
-
Medco Health Reports In-Line Q4 Earnings
Tuesday, February 22, 2011 - 7:44am | 58Medco Health Solutions Inc (NYSE: MHS) reports its Q4 adjusted EPS at $0.94, versus the consensus of $0.94. MHS reports its Q4 revenue at $16.93 billion, versus the consensus of $16.65 billion. MHS shares dropped 0.62% to $64.38 in after-hours trading. Read more from Benzinga's Company news.
-
Earnings Scheduled For February 22 (M, HPQ, MHS, WMT, BKS, MDT, ODP, NRG, HTZ, RSH, HD, CHK, MHK)
Tuesday, February 22, 2011 - 4:19am | 337Macy's Inc (NYSE: M) is projected to report its Q4 EPS at $1.52 on revenue of $8.27 billion. Hewlett-Packard Company (NYSE: HPQ) is estimated to report its FQ3 EPS at $1.29 on revenue of $32.95 billion. Medco Health (NYSE: MHS) is projected to post its Q4 EPS at $0.94 on revenue of $16.65 billion...
-
Morgan Keegan Gives Color On Athenahealth Following Earnings Results, Raises PT
Friday, February 18, 2011 - 12:01pm | 120Athenahealth (NASDAQ: ATHN) reported December results of $0.28 on $69.4 million versus the consensus of $0.20 on $67.6 million. Strong collections and higher Clinicals/Communicator penetration overcame a 3-4% reduction in average physician volumes. Higher levels of automation combined with some...
-
Jefferies Lowers PT on CardioNet to $5 (BEAT)
Friday, February 18, 2011 - 11:59am | 81Jefferies is out with its report today on CardioNet (NASDAQ: BEAT), lowering its price target from $6 to $5. In a note to clients, Jefferies writes, "BEAT reported weak Q4:10 results with slightly lower revenues and larger-than-expected losses. We remain sidelined into another challenging year. We...